> top > docs > PMC:7205724 > spans > 29433-30161 > annotations

PMC:7205724 / 29433-30161 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
1061 477-480 Gene denotes IL6 Gene:3569
1062 660-663 Gene denotes IL6 Gene:3569
1063 717-720 Gene denotes IL6 Gene:3569
1064 593-601 Species denotes patients Tax:9606
1065 698-706 Species denotes patients Tax:9606
1066 617-628 Chemical denotes Tocilizumab MESH:C502936
1067 15-23 Disease denotes COVID-19 MESH:C000657245
1068 47-59 Disease denotes inflammation MESH:D007249
1069 307-315 Disease denotes COVID-19 MESH:C000657245
1070 413-421 Disease denotes COVID-19 MESH:C000657245
1071 430-435 Disease denotes death MESH:D003643
1072 516-524 Disease denotes COVID-19 MESH:C000657245
1073 607-615 Disease denotes COVID-19 MESH:C000657245

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T213 468-476 Body_part denotes cytokine http://purl.org/sig/ont/fma/fma84050
T214 504-512 Body_part denotes cytokine http://purl.org/sig/ont/fma/fma84050
T215 643-651 Body_part denotes antibody http://purl.org/sig/ont/fma/fma62871

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T221 15-23 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T222 47-59 Disease denotes inflammation http://purl.obolibrary.org/obo/MONDO_0021166
T223 307-315 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T224 413-421 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T225 516-524 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T226 607-615 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T333 83-84 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T334 630-631 http://purl.obolibrary.org/obo/CLO_0001020 denotes a

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T236 260-275 Chemical denotes corticosteroids http://purl.obolibrary.org/obo/CHEBI_50858
T237 386-401 Chemical denotes corticosteroids http://purl.obolibrary.org/obo/CHEBI_50858

LitCovid-sample-MedDRA

Id Subject Object Predicate Lexical cue meddra_id
T30 564-574 http://purl.bioontology.org/ontology/MEDDRA/10022891 denotes viral load http://purl.bioontology.org/ontology/MEDDRA/10062178

LitCovid-sample-PD-IDO

Id Subject Object Predicate Lexical cue
T143 205-221 http://purl.obolibrary.org/obo/GO_0006955 denotes immune responses

LitCovid-sample-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T151 260-275 Chemical denotes corticosteroids http://purl.obolibrary.org/obo/CHEBI_50858
T152 386-401 Chemical denotes corticosteroids http://purl.obolibrary.org/obo/CHEBI_50858

LitCovid-sample-PD-NCBITaxon

Id Subject Object Predicate Lexical cue ncbi_taxonomy_id
T271 15-23 Species denotes COVID-19 NCBItxid:2697049
T272 307-315 Species denotes COVID-19 NCBItxid:2697049
T273 413-421 Species denotes COVID-19 NCBItxid:2697049
T274 516-524 Species denotes COVID-19 NCBItxid:2697049
T275 607-615 Species denotes COVID-19 NCBItxid:2697049

LitCovid-sample-sentences

Id Subject Object Predicate Lexical cue
T237 0-60 Sentence denotes Evidence links COVID-19 to variable degrees of inflammation.
T238 61-117 Sentence denotes Corticosteroids offer a potent anti-inflammatory option.
T239 118-230 Sentence denotes However, they do not dictate precise actions and might cause suppression of anti-viral immune responses as well.
T240 231-316 Sentence denotes Studies show that the use of corticosteroids might accelerate recovery from COVID-19.
T241 317-436 Sentence denotes There are no controlled clinical trials that show whether the use of corticosteroids can reduce COVID-19-related death.
T242 437-616 Sentence denotes Moreover, the pro-inflammatory cytokine IL6 is the best-documented cytokine in COVID-19 correlated with severity, criticality, viral load, and prognosis of patients with COVID-19.
T243 617-728 Sentence denotes Tocilizumab, a monoclonal antibody against IL6, could confer clinical benefit in patients with high IL6 levels.

LitCovid-sample-Pubtator

Id Subject Object Predicate Lexical cue pubann:denotes
1067 15-23 Disease denotes COVID-19 MESH:C000657245
1068 47-59 Disease denotes inflammation MESH:D007249
1069 307-315 Disease denotes COVID-19 MESH:C000657245
1070 413-421 Disease denotes COVID-19 MESH:C000657245
1071 430-435 Disease denotes death MESH:D003643
1061 477-480 Gene denotes IL6 Gene:3569
1072 516-524 Disease denotes COVID-19 MESH:C000657245
1064 593-601 Species denotes patients Tax:9606
1073 607-615 Disease denotes COVID-19 MESH:C000657245
1066 617-628 Chemical denotes Tocilizumab MESH:C502936
1062 660-663 Gene denotes IL6 Gene:3569
1065 698-706 Species denotes patients Tax:9606
1063 717-720 Gene denotes IL6 Gene:3569

LitCovid-sample-UniProt

Id Subject Object Predicate Lexical cue uniprot_id
T3157 477-480 Protein denotes IL6 https://www.uniprot.org/uniprot/Q9XT80|https://www.uniprot.org/uniprot/Q9UCU4|https://www.uniprot.org/uniprot/Q9UCU3|https://www.uniprot.org/uniprot/Q9UCU2|https://www.uniprot.org/uniprot/Q9MZR1|https://www.uniprot.org/uniprot/Q9MYZ7|https://www.uniprot.org/uniprot/Q95KN6|https://www.uniprot.org/uniprot/Q95181|https://www.uniprot.org/uniprot/Q90YI0|https://www.uniprot.org/uniprot/Q8MKH0|https://www.uniprot.org/uniprot/Q8BN26|https://www.uniprot.org/uniprot/Q865X6|https://www.uniprot.org/uniprot/Q865W7|https://www.uniprot.org/uniprot/Q6V919|https://www.uniprot.org/uniprot/Q6L6X6|https://www.uniprot.org/uniprot/Q5I6E3|https://www.uniprot.org/uniprot/Q3UCQ0|https://www.uniprot.org/uniprot/Q2MH06|https://www.uniprot.org/uniprot/Q28819|https://www.uniprot.org/uniprot/Q28747|https://www.uniprot.org/uniprot/Q28319|https://www.uniprot.org/uniprot/Q25BC2|https://www.uniprot.org/uniprot/Q0PW36|https://www.uniprot.org/uniprot/Q0GGL7|https://www.uniprot.org/uniprot/Q08DT2|https://www.uniprot.org/uniprot/P79341|https://www.uniprot.org/uniprot/P51494|https://www.uniprot.org/uniprot/P46650|https://www.uniprot.org/uniprot/P41693|https://www.uniprot.org/uniprot/P41683|https://www.uniprot.org/uniprot/P41323|https://www.uniprot.org/uniprot/P29455|https://www.uniprot.org/uniprot/P26893|https://www.uniprot.org/uniprot/P26892|https://www.uniprot.org/uniprot/P20607|https://www.uniprot.org/uniprot/P08505|https://www.uniprot.org/uniprot/P05231|https://www.uniprot.org/uniprot/O46568|https://www.uniprot.org/uniprot/O35736|https://www.uniprot.org/uniprot/O19007|https://www.uniprot.org/uniprot/B6CKP4|https://www.uniprot.org/uniprot/A9QWQ9|https://www.uniprot.org/uniprot/A3FBE9|https://www.uniprot.org/uniprot/A0S0B0
T3201 660-663 Protein denotes IL6 https://www.uniprot.org/uniprot/Q9XT80|https://www.uniprot.org/uniprot/Q9UCU4|https://www.uniprot.org/uniprot/Q9UCU3|https://www.uniprot.org/uniprot/Q9UCU2|https://www.uniprot.org/uniprot/Q9MZR1|https://www.uniprot.org/uniprot/Q9MYZ7|https://www.uniprot.org/uniprot/Q95KN6|https://www.uniprot.org/uniprot/Q95181|https://www.uniprot.org/uniprot/Q90YI0|https://www.uniprot.org/uniprot/Q8MKH0|https://www.uniprot.org/uniprot/Q8BN26|https://www.uniprot.org/uniprot/Q865X6|https://www.uniprot.org/uniprot/Q865W7|https://www.uniprot.org/uniprot/Q6V919|https://www.uniprot.org/uniprot/Q6L6X6|https://www.uniprot.org/uniprot/Q5I6E3|https://www.uniprot.org/uniprot/Q3UCQ0|https://www.uniprot.org/uniprot/Q2MH06|https://www.uniprot.org/uniprot/Q28819|https://www.uniprot.org/uniprot/Q28747|https://www.uniprot.org/uniprot/Q28319|https://www.uniprot.org/uniprot/Q25BC2|https://www.uniprot.org/uniprot/Q0PW36|https://www.uniprot.org/uniprot/Q0GGL7|https://www.uniprot.org/uniprot/Q08DT2|https://www.uniprot.org/uniprot/P79341|https://www.uniprot.org/uniprot/P51494|https://www.uniprot.org/uniprot/P46650|https://www.uniprot.org/uniprot/P41693|https://www.uniprot.org/uniprot/P41683|https://www.uniprot.org/uniprot/P41323|https://www.uniprot.org/uniprot/P29455|https://www.uniprot.org/uniprot/P26893|https://www.uniprot.org/uniprot/P26892|https://www.uniprot.org/uniprot/P20607|https://www.uniprot.org/uniprot/P08505|https://www.uniprot.org/uniprot/P05231|https://www.uniprot.org/uniprot/O46568|https://www.uniprot.org/uniprot/O35736|https://www.uniprot.org/uniprot/O19007|https://www.uniprot.org/uniprot/B6CKP4|https://www.uniprot.org/uniprot/A9QWQ9|https://www.uniprot.org/uniprot/A3FBE9|https://www.uniprot.org/uniprot/A0S0B0
T3245 717-720 Protein denotes IL6 https://www.uniprot.org/uniprot/Q9XT80|https://www.uniprot.org/uniprot/Q9UCU4|https://www.uniprot.org/uniprot/Q9UCU3|https://www.uniprot.org/uniprot/Q9UCU2|https://www.uniprot.org/uniprot/Q9MZR1|https://www.uniprot.org/uniprot/Q9MYZ7|https://www.uniprot.org/uniprot/Q95KN6|https://www.uniprot.org/uniprot/Q95181|https://www.uniprot.org/uniprot/Q90YI0|https://www.uniprot.org/uniprot/Q8MKH0|https://www.uniprot.org/uniprot/Q8BN26|https://www.uniprot.org/uniprot/Q865X6|https://www.uniprot.org/uniprot/Q865W7|https://www.uniprot.org/uniprot/Q6V919|https://www.uniprot.org/uniprot/Q6L6X6|https://www.uniprot.org/uniprot/Q5I6E3|https://www.uniprot.org/uniprot/Q3UCQ0|https://www.uniprot.org/uniprot/Q2MH06|https://www.uniprot.org/uniprot/Q28819|https://www.uniprot.org/uniprot/Q28747|https://www.uniprot.org/uniprot/Q28319|https://www.uniprot.org/uniprot/Q25BC2|https://www.uniprot.org/uniprot/Q0PW36|https://www.uniprot.org/uniprot/Q0GGL7|https://www.uniprot.org/uniprot/Q08DT2|https://www.uniprot.org/uniprot/P79341|https://www.uniprot.org/uniprot/P51494|https://www.uniprot.org/uniprot/P46650|https://www.uniprot.org/uniprot/P41693|https://www.uniprot.org/uniprot/P41683|https://www.uniprot.org/uniprot/P41323|https://www.uniprot.org/uniprot/P29455|https://www.uniprot.org/uniprot/P26893|https://www.uniprot.org/uniprot/P26892|https://www.uniprot.org/uniprot/P20607|https://www.uniprot.org/uniprot/P08505|https://www.uniprot.org/uniprot/P05231|https://www.uniprot.org/uniprot/O46568|https://www.uniprot.org/uniprot/O35736|https://www.uniprot.org/uniprot/O19007|https://www.uniprot.org/uniprot/B6CKP4|https://www.uniprot.org/uniprot/A9QWQ9|https://www.uniprot.org/uniprot/A3FBE9|https://www.uniprot.org/uniprot/A0S0B0

LitCovid-sample-Enju

Id Subject Object Predicate Lexical cue
T60314 0-8 NN denotes Evidence
T35183 9-14 VBZ denotes links
T72324 15-23 NN denotes COVID-19
T95206 24-26 TO denotes to
T97915 27-35 JJ denotes variable
T92397 36-43 NNS denotes degrees
T70831 44-46 IN denotes of
T73708 47-59 NN denotes inflammation
T93832 61-76 NNS denotes Corticosteroids
T86571 77-82 VBP denotes offer
T20640 83-84 DT denotes a
T11737 85-91 JJ denotes potent
T13881 92-109 JJ denotes anti-inflammatory
T85869 110-116 NN denotes option
T39590 118-125 RB denotes However
T9841 125-126 -COMMA- denotes ,
T82570 127-131 PRP denotes they
T33328 132-134 VBP denotes do
T52824 135-138 RB denotes not
T27396 139-146 VB denotes dictate
T37147 147-154 JJ denotes precise
T31383 155-162 NNS denotes actions
T30144 163-166 CC denotes and
T43608 167-172 MD denotes might
T71924 173-178 VB denotes cause
T87293 179-190 NN denotes suppression
T66079 191-193 IN denotes of
T8269 194-204 JJ denotes anti-viral
T52172 205-211 JJ denotes immune
T20124 212-221 NNS denotes responses
T85154 222-224 RB denotes as
T9965 225-229 RB denotes well
T92497 231-238 NNS denotes Studies
T44468 239-243 VBP denotes show
T92811 244-248 IN denotes that
T62828 249-252 DT denotes the
T64812 253-256 NN denotes use
T90977 257-259 IN denotes of
T15178 260-275 NNS denotes corticosteroids
T25429 276-281 MD denotes might
T69842 282-292 VB denotes accelerate
T80684 293-301 NN denotes recovery
T88404 302-306 IN denotes from
T21137 307-315 NN denotes COVID-19
T1899 317-322 EX denotes There
T21793 323-326 VBP denotes are
T48698 327-329 DT denotes no
T88569 330-340 JJ denotes controlled
T72804 341-349 JJ denotes clinical
T97339 350-356 NNS denotes trials
T48573 357-361 WDT denotes that
T30904 362-366 VBP denotes show
T93994 367-374 IN denotes whether
T4378 375-378 DT denotes the
T44216 379-382 NN denotes use
T95916 383-385 IN denotes of
T36033 386-401 NNS denotes corticosteroids
T95640 402-405 MD denotes can
T86415 406-412 VB denotes reduce
T37383 413-429 JJ denotes COVID-19-related
T11797 430-435 NN denotes death
T74879 437-445 RB denotes Moreover
T90599 445-446 -COMMA- denotes ,
T98284 447-450 DT denotes the
T49609 451-467 JJ denotes pro-inflammatory
T24072 468-476 NN denotes cytokine
T64274 477-480 NN denotes IL6
T39845 481-483 VBZ denotes is
T48453 484-487 DT denotes the
T6053 488-503 JJ denotes best-documented
T54874 504-512 NN denotes cytokine
T84071 513-515 IN denotes in
T3462 516-524 NN denotes COVID-19
T4397 525-535 VBD denotes correlated
T53541 536-540 IN denotes with
T9169 541-549 NN denotes severity
T52339 549-550 -COMMA- denotes ,
T9027 551-562 NN denotes criticality
T63816 562-563 -COMMA- denotes ,
T3842 564-569 JJ denotes viral
T33160 570-574 NN denotes load
T71418 574-575 -COMMA- denotes ,
T44925 576-579 CC denotes and
T24005 580-589 NN denotes prognosis
T43722 590-592 IN denotes of
T77279 593-601 NNS denotes patients
T53860 602-606 IN denotes with
T83045 607-615 NN denotes COVID-19
T91725 617-628 NNP denotes Tocilizumab
T13491 628-629 -COMMA- denotes ,
T55969 630-631 DT denotes a
T88153 632-642 JJ denotes monoclonal
T13966 643-651 NN denotes antibody
T87639 652-659 IN denotes against
T20271 660-663 NN denotes IL6
T22072 663-664 -COMMA- denotes ,
T26781 665-670 MD denotes could
T93033 671-677 VB denotes confer
T66151 678-686 JJ denotes clinical
T39668 687-694 NN denotes benefit
T93255 695-697 IN denotes in
T16710 698-706 NNS denotes patients
T86610 707-711 IN denotes with
T16499 712-716 JJ denotes high
T41273 717-720 NN denotes IL6
T27148 721-727 NNS denotes levels
R55247 T92397 T95206 arg2Of degrees,to
R92120 T63816 T44925 arg1Of ",",and
R32306 T60314 T35183 arg1Of Evidence,links
R19129 T72324 T35183 arg2Of COVID-19,links
R25853 T35183 T95206 arg1Of links,to
R65223 T92397 T97915 arg1Of degrees,variable
R29631 T92397 T70831 arg1Of degrees,of
R66024 T73708 T70831 arg2Of inflammation,of
R53561 T93832 T86571 arg1Of Corticosteroids,offer
R61578 T85869 T86571 arg2Of option,offer
R17185 T85869 T20640 arg1Of option,a
R26499 T85869 T11737 arg1Of option,potent
R43732 T85869 T13881 arg1Of option,anti-inflammatory
R38807 T30144 T39590 arg1Of and,However
R59317 T30144 T9841 arg1Of and,","
R9092 T82570 T33328 arg1Of they,do
R20630 T27396 T33328 arg2Of dictate,do
R37965 T27396 T52824 arg1Of dictate,not
R99599 T82570 T27396 arg1Of they,dictate
R94411 T31383 T27396 arg2Of actions,dictate
R65208 T31383 T37147 arg1Of actions,precise
R81898 T27396 T30144 arg1Of dictate,and
R91050 T71924 T30144 arg2Of cause,and
R93772 T82570 T43608 arg1Of they,might
R96557 T71924 T43608 arg2Of cause,might
R82268 T82570 T71924 arg1Of they,cause
R67688 T87293 T71924 arg2Of suppression,cause
R72835 T87293 T66079 arg1Of suppression,of
R60797 T20124 T66079 arg2Of responses,of
R42302 T20124 T8269 arg1Of responses,anti-viral
R34762 T20124 T52172 arg1Of responses,immune
R87076 T9965 T85154 arg1Of well,as
R33081 T71924 T9965 arg1Of cause,well
R22782 T92497 T44468 arg1Of Studies,show
R18642 T69842 T44468 arg2Of accelerate,show
R76777 T69842 T92811 arg1Of accelerate,that
R96241 T64812 T62828 arg1Of use,the
R57789 T64812 T90977 arg1Of use,of
R42521 T15178 T90977 arg2Of corticosteroids,of
R52693 T64812 T25429 arg1Of use,might
R75916 T69842 T25429 arg2Of accelerate,might
R43795 T64812 T69842 arg1Of use,accelerate
R20459 T80684 T69842 arg2Of recovery,accelerate
R86356 T80684 T88404 arg1Of recovery,from
R21604 T21137 T88404 arg2Of COVID-19,from
R43872 T1899 T21793 arg1Of There,are
R66576 T97339 T21793 arg2Of trials,are
R77390 T97339 T48698 arg1Of trials,no
R65755 T72804 T88569 arg1Of clinical,controlled
R38259 T97339 T72804 arg1Of trials,clinical
R69637 T97339 T48573 arg1Of trials,that
R29960 T97339 T30904 arg1Of trials,show
R57398 T86415 T30904 arg2Of reduce,show
R33558 T86415 T93994 arg1Of reduce,whether
R72524 T44216 T4378 arg1Of use,the
R7741 T44216 T95916 arg1Of use,of
R74181 T36033 T95916 arg2Of corticosteroids,of
R85296 T44216 T95640 arg1Of use,can
R35205 T86415 T95640 arg2Of reduce,can
R35783 T44216 T86415 arg1Of use,reduce
R54861 T11797 T86415 arg2Of death,reduce
R14968 T11797 T37383 arg1Of death,COVID-19-related
R65897 T39845 T74879 arg1Of is,Moreover
R46266 T39845 T90599 arg1Of is,","
R45534 T64274 T98284 arg1Of IL6,the
R76858 T64274 T49609 arg1Of IL6,pro-inflammatory
R33432 T64274 T24072 arg1Of IL6,cytokine
R50943 T64274 T39845 arg1Of IL6,is
R49022 T54874 T39845 arg2Of cytokine,is
R47959 T54874 T48453 arg1Of cytokine,the
R12734 T54874 T6053 arg1Of cytokine,best-documented
R7429 T54874 T84071 arg1Of cytokine,in
R83809 T44925 T84071 arg2Of and,in
R87187 T3462 T4397 arg2Of COVID-19,correlated
R92110 T4397 T53541 arg1Of correlated,with
R68265 T9169 T53541 arg2Of severity,with
R96435 T9169 T52339 arg1Of severity,","
R33111 T9027 T52339 arg2Of criticality,","
R71697 T3462 T63816 arg1Of COVID-19,","
R27015 T33160 T63816 arg2Of load,","
R35581 T33160 T3842 arg1Of load,viral
R19463 T44925 T71418 arg1Of and,","
R7472 T24005 T44925 arg2Of prognosis,and
R21271 T24005 T43722 arg1Of prognosis,of
R63382 T77279 T43722 arg2Of patients,of
R59863 T77279 T53860 arg1Of patients,with
R14281 T83045 T53860 arg2Of COVID-19,with
R83532 T91725 T13491 arg1Of Tocilizumab,","
R16595 T13966 T13491 arg2Of antibody,","
R73426 T13966 T55969 arg1Of antibody,a
R70938 T13966 T88153 arg1Of antibody,monoclonal
R83956 T13966 T87639 arg1Of antibody,against
R94996 T20271 T87639 arg2Of IL6,against
R94172 T93033 T22072 arg1Of confer,","
R9162 T91725 T26781 arg1Of Tocilizumab,could
R79231 T93033 T26781 arg2Of confer,could
R97743 T91725 T93033 arg1Of Tocilizumab,confer
R40528 T39668 T93033 arg2Of benefit,confer
R97670 T39668 T66151 arg1Of benefit,clinical
R49090 T93033 T93255 arg1Of confer,in
R27028 T16710 T93255 arg2Of patients,in
R2338 T16710 T86610 arg1Of patients,with
R11456 T27148 T86610 arg2Of levels,with
R76677 T27148 T16499 arg1Of levels,high
R64079 T27148 T41273 arg1Of levels,IL6

LitCovid-sample-PD-GO-BP-0

Id Subject Object Predicate Lexical cue
T55 47-59 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammation
T56 205-221 http://purl.obolibrary.org/obo/GO_0006955 denotes immune responses
T57 430-435 http://purl.obolibrary.org/obo/GO_0016265 denotes death

LitCovid-sample-PD-FMA

Id Subject Object Predicate Lexical cue fma_id
T213 468-476 Body_part denotes cytokine http://purl.org/sig/ont/fma/fma84050
T214 504-512 Body_part denotes cytokine http://purl.org/sig/ont/fma/fma84050
T215 643-651 Body_part denotes antibody http://purl.org/sig/ont/fma/fma62871

LitCovid-sample-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T211 15-23 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T212 47-59 Disease denotes inflammation http://purl.obolibrary.org/obo/MONDO_0021166
T213 307-315 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T214 413-421 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T215 516-524 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T216 607-615 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096

LitCovid-sample-GO-BP

Id Subject Object Predicate Lexical cue
T50 47-59 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammation
T51 205-221 http://purl.obolibrary.org/obo/GO_0006955 denotes immune responses

LitCovid-PD-GO-BP

Id Subject Object Predicate Lexical cue
T50 47-59 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammation
T51 205-221 http://purl.obolibrary.org/obo/GO_0006955 denotes immune responses

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T237 0-60 Sentence denotes Evidence links COVID-19 to variable degrees of inflammation.
T238 61-117 Sentence denotes Corticosteroids offer a potent anti-inflammatory option.
T239 118-230 Sentence denotes However, they do not dictate precise actions and might cause suppression of anti-viral immune responses as well.
T240 231-316 Sentence denotes Studies show that the use of corticosteroids might accelerate recovery from COVID-19.
T241 317-436 Sentence denotes There are no controlled clinical trials that show whether the use of corticosteroids can reduce COVID-19-related death.
T242 437-616 Sentence denotes Moreover, the pro-inflammatory cytokine IL6 is the best-documented cytokine in COVID-19 correlated with severity, criticality, viral load, and prognosis of patients with COVID-19.
T243 617-728 Sentence denotes Tocilizumab, a monoclonal antibody against IL6, could confer clinical benefit in patients with high IL6 levels.